A detailed history of Jane Street Group, LLC transactions in Biovie Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 176,236 shares of BIVI stock, worth $207,958. This represents 0.0% of its overall portfolio holdings.

Number of Shares
176,236
Holding current value
$207,958
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.4 - $0.56 $70,494 - $98,692
176,236 New
176,236 $70,000
Q1 2023

May 15, 2023

BUY
$4.89 - $10.53 $126,142 - $271,631
25,796 New
25,796 $208,000

Others Institutions Holding BIVI

About BIOVIE INC.


  • Ticker BIVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,165,300
  • Market Cap $35.6M
  • Description
  • BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial ...
More about BIVI
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.